<DOC>
	<DOCNO>NCT00395577</DOCNO>
	<brief_summary>The purpose study assess safety effect VX-702 subject moderate severe rheumatoid arthritis take drug methotrexate .</brief_summary>
	<brief_title>A Study Rheumatoid Arthritis With Investigational Oral p38 MAP Kinase Inhibitor VX-702</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Adult patient 18 75 year age active RA Must take MTX least 6 month No concurrent DMARD treatment ( stable dose MTX ) Planned major surgery ( e.g. , joint replacement ) within duration treatment period study Treated intraarticular injection corticosteroid within 28 day prior Day 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>